Rep. Markey has long been in favor of sweeping FDA overhaul, aimed at restoring the public's faith in the drug approval system. In a FDA reform bill singed into law in 2007, Rep. Markey negotiated provisions to give the FDA the authority to require label changes, order post-market studies to follow up on safety concerns and gather information needed to reassess the risks compared to the benefits of a drug already on the market, as well as establish an online clinical trials registry and a clinical trials results database, both available to the public.